CLINICAL_TRIALS
trial_result
· 2013-05-27
Clinical Trial Update: Effect of Metoprolol on Thalassemia Cardiomyopathy [Phase 2, Phase 3]
Summary
A completed Phase 2/3 clinical trial evaluated metoprolol for beta-thalassemia cardiomyopathy.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shiraz University of Medical Sciences | Conditions: B Thalassemia | Phase 2, Phase 3 | Status: COMPLETED